Canada
· Delayed Price · Currency is CAD Ovation Science Statistics
Total Valuation
Ovation Science has a market cap or net worth of CAD 1.06 million. The enterprise value is 1.32 million.
| Market Cap | 1.06M |
| Enterprise Value | 1.32M |
Important Dates
The last earnings date was Thursday, May 1, 2025.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ovation Science has 35.24 million shares outstanding. The number of shares has increased by 50.45% in one year.
| Current Share Class | 35.24M |
| Shares Outstanding | 35.24M |
| Shares Change (YoY) | +50.45% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 25.13% |
| Owned by Institutions (%) | n/a |
| Float | 26.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.34 |
| PB Ratio | -0.97 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.90 |
| EV / Sales | 11.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06
| Current Ratio | 0.06 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.59 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -425.32% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 43.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.61 |
| Inventory Turnover | 1.19 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.45% in the last 52 weeks. The beta is 0.44, so Ovation Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -45.45% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 31.56 |
| Average Volume (20 Days) | 1,800 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ovation Science had revenue of CAD 113,215 and -456,197 in losses. Loss per share was -0.01.
| Revenue | 113,215 |
| Gross Profit | 85,718 |
| Operating Income | -479,034 |
| Pretax Income | -456,197 |
| Net Income | -456,197 |
| EBITDA | -476,918 |
| EBIT | -479,034 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 3,312 in cash and 268,478 in debt, giving a net cash position of -265,166 or -0.01 per share.
| Cash & Cash Equivalents | 3,312 |
| Total Debt | 268,478 |
| Net Cash | -265,166 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -1.09M |
| Book Value Per Share | -0.03 |
| Working Capital | -1.09M |
Cash Flow
| Operating Cash Flow | -178,819 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 75.71% |
| Operating Margin | -423.12% |
| Pretax Margin | -402.95% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Ovation Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -50.45% |
| Shareholder Yield | -50.45% |
| Earnings Yield | -43.15% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |